Incyte Tosses IO Candidates To Focus On High-Value Pipeline Assets

 
• By Alaric DeArment
  
Incyte shuffled its pipeline in Q2, discontinuing several IO programs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business